About C-terminal-binding protein 1
C-terminal-binding protein 1 (CTBP1) is a protein
from Homo sapiens identified by UniProt accession
Q13363, 440 residues long.
MolForge cross-references it against 0 known binders and
249 disease associations.
Target properties
| Protein name | C-terminal-binding protein 1 |
| UniProt accession | Q13363 |
| Gene | CTBP1 |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (249)
Diseases linked to this target (Open Targets).
- hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome · score 0.65
- genetic disorder · score 0.41
- type 2 diabetes mellitus · score 0.39
- Drugs used in diabetes use measurement · score 0.31
- Intellectual disability · score 0.27
- glucose measurement · score 0.25
- endometrial cancer · score 0.25
- pulse pressure measurement · score 0.24
- thyroid gland adenocarcinoma · score 0.23
- attention deficit hyperactivity disorder · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13363-F1 | alphafold | PREDICTED | 83.28 | — |
Amino-acid sequence (440 residues)
MGSSHLLNKG LPLGVRPPIM NGPLHPRPLV ALLDGRDCTV EMPILKDVAT VAFCDAQSTQ EIHEKVLNEA VGALMYHTIT LTREDLEKFK ALRIIVRIGS GFDNIDIKSA GDLGIAVCNV PAASVEETAD STLCHILNLY RRATWLHQAL REGTRVQSVE QIREVASGAA RIRGETLGII GLGRVGQAVA LRAKAFGFNV LFYDPYLSDG VERALGLQRV STLQDLLFHS DCVTLHCGLN EHNHHLINDF TVKQMRQGAF LVNTARGGLV DEKALAQALK EGRIRGAALD VHESEPFSFS QGPLKDAPNL ICTPHAAWYS EQASIEMREE AAREIRRAIT GRIPDSLKNC VNKDHLTAAT HWASMDPAVV HPELNGAAYR YPPGVVGVAP TGIPAAVEGI VPSAMSLSHG LPPVAHPPHA PSPGQTVKPE ADRDHASDQL
Explore C-terminal-binding protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets